-
公开(公告)号：US08309104B2
公开(公告)日：2012-11-13
申请号：US11712133
申请日：2007-02-28
Applicant: Xiu Xiu Cheng , Dacheng Tian
Inventor： Xiu Xiu Cheng , Dacheng Tian
CPC classification number: A61K9/2846 , A61K9/2866
Abstract: The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration.
Abstract translation: 本发明涉及一种在给药后快速释放镇静剂或催眠剂的治疗量的新型控释剂型，并且在给药后约8小时维持治疗水平。
-
公开(公告)号：US20110165234A1
公开(公告)日：2011-07-07
申请号：US13051076
申请日：2011-03-18
Applicant: Manesh Dixit , Xiu-Xiu Cheng , Avinash Nangia , Chin Ming Chen
Inventor： Manesh Dixit , Xiu-Xiu Cheng , Avinash Nangia , Chin Ming Chen
IPC: A61K9/58 , A61K9/16 , A61K31/135 , A61K9/24
CPC classification number: A61K9/48 , A61K9/1676 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K9/5078 , A61K9/5084 , A61K31/137
Abstract: A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
Abstract translation: 文拉法辛的控释剂型，其包含速释丸和延长释放丸。
-
公开(公告)号：US07713550B2
公开(公告)日：2010-05-11
申请号：US10868286
申请日：2004-06-15
Applicant: Nilobon Podhipleux , Xiu Xiu Cheng , Unchalee Lodin , Chih-Ming Chen , Avinash Nangia , Dacheng Tian
Inventor： Nilobon Podhipleux , Xiu Xiu Cheng , Unchalee Lodin , Chih-Ming Chen , Avinash Nangia , Dacheng Tian
CPC classification number: A61K9/2072 , A61K9/1652 , A61K9/2866 , A61K31/19
Abstract: Disclosed is a controlled release formulation comprising valproic acid, pharmaceutically acceptable salt thereof, amide thereof, or derivative thereof.
Abstract translation: 公开了包含丙戊酸，其药学上可接受的盐，其酰胺或其衍生物的控释制剂。
-
公开(公告)号：US20090123535A1
公开(公告)日：2009-05-14
申请号：US12328240
申请日：2008-12-04
Applicant: Xiu Xiu Cheng , Dacheng Tian
Inventor： Xiu Xiu Cheng , Dacheng Tian
IPC: A61K9/52 , A61K31/437 , A61P25/20 , A61K9/22
CPC classification number: A61K9/2846 , A61K9/2866
Abstract: The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration.
Abstract translation: 本发明涉及一种在给药后快速释放镇静剂或催眠剂的治疗量的新型控释剂型，并且在给药后约8小时维持治疗水平。
-
公开(公告)号：US20050287185A1
公开(公告)日：2005-12-29
申请号：US10902739
申请日：2004-07-29
Applicant: David Wong , Xiu Cheng , Chih-Ming Chen , Steve Jan , Aaron Dely , Dacheng Tian
Inventor： David Wong , Xiu Cheng , Chih-Ming Chen , Steve Jan , Aaron Dely , Dacheng Tian
CPC classification number: A61K9/0004
Abstract: A controlled release oxybutynin tablet that employs a homogeneous core with less than 50% of a water swellable polymer and a semi-permeable membrane that surrounds the homogeneous core.
Abstract translation: 一种控制释放的奥昔布宁片剂，其使用具有小于50％的可溶胀聚合物的均质核心和围绕该均质核心的半透膜。
-
Patent Agency Ranking
公开(公告)号：US20050166688A1
公开(公告)日：2005-08-04
申请号：US10768277
申请日：2004-01-30
Applicant: Dacheng Tian , Xiu Cheng , Jack Cardinal , Boyong Li , Avinash Nangia
Inventor： Dacheng Tian , Xiu Cheng , Jack Cardinal , Boyong Li , Avinash Nangia
CPC classification number: G01N13/00 , G01N33/15 , G01N2013/006
Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
Abstract translation: 本发明包括用于溶解或浸渍试验的装置和方法，特别是通过限制药物或其它剂型在测试期间移动或重新定向的能力来提高试验结果的一致性的装置和方法。
-
7.发明申请Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug 审中-公开含有非甾体抗炎药物和抗溃疡药物的药物制剂公开(公告)号：US20050163847A1
公开(公告)日：2005-07-28
申请号：US11039489
申请日：2005-01-20
Applicant: Xiu Cheng , Avinash Nangia , Dacheng Tian
Inventor： Xiu Cheng , Avinash Nangia , Dacheng Tian
IPC: A61K9/16 , A61K9/20 , A61K9/24 , A61K31/192 , A61K31/405 , A61K31/60
CPC classification number: A61K31/192 , A61K9/1676 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K31/405 , A61K31/60 , A61K2300/00
Abstract: Disclosed is a pharmaceutical dosage form including a therapeutically effective amount of an NSAID and an antiulcerative agent.
Abstract translation: 公开了包含治疗有效量的NSAID和抗溃疡剂的药物剂型。
-
公开(公告)号：US09468633B2
公开(公告)日：2016-10-18
申请号：US13590061
申请日：2012-08-20
Applicant: Manesh Dixit , Chih-Ming Chen , Xiu Xiu Cheng , Jianbo Xie
Inventor： Manesh Dixit , Chih-Ming Chen , Xiu Xiu Cheng , Jianbo Xie
IPC: A61K9/48 , A61K9/26 , A61K31/445 , A61K9/24
CPC classification number: A61K31/445 , A61K9/209
Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
Abstract translation: 提供用于口服给予中枢神经系统兴奋剂，优选哌甲酯盐酸盐的控释固体剂型的剂型。
-
公开(公告)号：US08778395B2
公开(公告)日：2014-07-15
申请号：US11201747
申请日：2005-08-11
Applicant: Xiu Xiu Cheng , Xiaohong Qi , Guohua Zhang , Manesh Dixit
Inventor： Xiu Xiu Cheng , Xiaohong Qi , Guohua Zhang , Manesh Dixit
IPC: A61K9/26 , A61K31/554
CPC classification number: A61K9/5078 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2081 , A61K9/5026 , A61K9/5084 , A61K31/554
Abstract: A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
Abstract translation: 含有多个地尔硫卓丸剂和凝胶形成物质的控释剂地尔硫卓剂量制剂，其中施用后8小时内发生最大地尔硫卓血浆水平的时间，优选施用后10小时以上。
-
公开(公告)号：US08747898B2
公开(公告)日：2014-06-10
申请号：US12835863
申请日：2010-07-14
Applicant: Boyong Li , Avinash Nangia , Chih Ming Chen , Xiu Xiu Cheng
Inventor： Boyong Li , Avinash Nangia , Chih Ming Chen , Xiu Xiu Cheng
CPC classification number: A61K31/137 , A61K9/1676 , A61K9/2081 , A61K9/5078 , A61K9/5084
Abstract: A once a day bupropion salt formulation is disclosed.
Abstract translation: 公开了一天一次的安非他酮盐配方。
-
-
-
-
-
-
-
-
-
Search Results
62
records
(took 0.017 seconds)
